» Articles » PMID: 33986324

Distribution of Estimated Glomerular Filtration Rate and Determinants of Its Age Dependent Loss in a German Population-based Study

Overview
Journal Sci Rep
Specialty Science
Date 2021 May 14
PMID 33986324
Citations 34
Authors
Affiliations
Soon will be listed here.
Abstract

Glomerular filtration rate (GFR) declines with age by approx. 1 ml/min/m per year beginning in the third decade of life. At 70 years of age > 40 ml/min/m of GFR will be lost. Thus, factors affecting loss of GFR have significant public health implications. Furthermore, the definition of chronic kidney disease based on GFR may not be appropriate for the elderly. We analyzed factors affecting absolute and relative change of eGFR over a 5 year period in 12,381 participants of the Gutenberg Health Study. We estimated GFR at baseline and after 5 years of follow-up by two different equations. Association with the decline of estimated GFR (eGFR) was assessed by multivariable regression analysis. We confirmed a median loss of eGFR per year of approx. 1 ml/min/m. Aside from albuminuria systolic blood pressure was most strongly associated with faster decline of eGFR followed by echocardiographic evidence of left ventricular diastolic dysfunction and reduced ejection fraction. White blood cell count showed a moderate association with eGFR loss. Diastolic blood pressure, serum uric acid and serum albumin were associated with slower GFR decline in multivariable analysis. Sensitivity analysis with exclusion of individuals taking diuretics, antihypertensive, antidiabetic, or lipid lowering drugs confirmed these associations.

Citing Articles

Impact of enzyme replacement therapy and migalastat on disease progression in females with fabry disease.

Lenders M, Nowak A, Cybulla M, Kaufeld J, Kohn A, Muschol N Orphanet J Rare Dis. 2025; 20(1):79.

PMID: 39980015 PMC: 11843741. DOI: 10.1186/s13023-025-03600-y.


Deep learning-based histopathological assessment of tubulo-interstitial injury in chronic kidney diseases.

Suzuki N, Kojima K, Malvica S, Yamasaki K, Chikamatsu Y, Oe Y Commun Med (Lond). 2025; 5(1):3.

PMID: 39757253 PMC: 11701080. DOI: 10.1038/s43856-024-00708-3.


Impact of enzyme replacement therapy on clinical manifestations in females with Fabry disease.

Lenders M, Nowak A, Cybulla M, Kaufeld J, Kohn A, Muschol N Orphanet J Rare Dis. 2024; 19(1):490.

PMID: 39731156 PMC: 11673826. DOI: 10.1186/s13023-024-03503-4.


Effect of an intensive lifestyle intervention on cystatin C-based kidney function in adults with overweight and obesity: From the PREDIMED-Plus trial.

Martinez-Montoro J, Cornejo-Pareja I, Diaz-Lopez A, Sureda A, Toledo E, Abete I J Intern Med. 2024; 297(2):141-155.

PMID: 39723807 PMC: 11771574. DOI: 10.1111/joim.20038.


The Global Kidney Patient Trials Network and the CAPTIVATE Platform Clinical Trial Design: A Trial Protocol.

Kotwal S, Perkovic V, Jardine M, Kim D, Shah N, Lin E JAMA Netw Open. 2024; 7(12):e2449998.

PMID: 39661388 PMC: 11635535. DOI: 10.1001/jamanetworkopen.2024.49998.


References
1.
Panova-Noeva M, Arnold N, Hermanns M, Prochaska J, Schulz A, Spronk H . Mean Platelet Volume and Arterial Stiffness - Clinical Relationship and Common Genetic Variability. Sci Rep. 2017; 7:40229. PMC: 5216402. DOI: 10.1038/srep40229. View

2.
Delanaye P, Jager K, Bokenkamp A, Christensson A, Dubourg L, Eriksen B . CKD: A Call for an Age-Adapted Definition. J Am Soc Nephrol. 2019; 30(10):1785-1805. PMC: 6779354. DOI: 10.1681/ASN.2019030238. View

3.
Grams M, Rebholz C, Chen Y, Rawlings A, Estrella M, Selvin E . Race, APOL1 Risk, and eGFR Decline in the General Population. J Am Soc Nephrol. 2016; 27(9):2842-50. PMC: 5004654. DOI: 10.1681/ASN.2015070763. View

4.
Eriksen B, Stefansson V, Jenssen T, Mathisen U, Schei J, Solbu M . Blood pressure and age-related GFR decline in the general population. BMC Nephrol. 2017; 18(1):77. PMC: 5331738. DOI: 10.1186/s12882-017-0496-7. View

5.
Schnabel R, Wild P, Schulz A, Zeller T, Sinning C, Wilde S . Multiple endothelial biomarkers and noninvasive vascular function in the general population: the Gutenberg Health Study. Hypertension. 2012; 60(2):288-95. DOI: 10.1161/HYPERTENSIONAHA.112.191874. View